Hims Hers Health is trading 7.24% down at $29.47 after its August 10, 2026 earnings release, as a GAAP loss of $0.37 per share missed the expected $0.05 loss.

  • Revenue reached $753.2 million, while gross margin fell to 64%.
  • Branded weight-loss products and international expansion pressured profitability.
  • Management raised revenue guidance, but investors appear focused on near-term margin contraction and restructuring costs.